Literature DB >> 21194302

An approach to diabetes mellitus in hospice and palliative medicine.

Mark Angelo1, Charles Ruchalski, Barbara J Sproge.   

Abstract

Abstract Hospice and palliative medicine practitioners frequently encounter diabetes and associated complications as comorbidities in end-of-life patients. As the patient with diabetes approaches end-of-life, there comes a time when tight glycemic control can not only prove of questionable benefit, but has the potential to cause harm. The medical literature offers little guidance on managing these complications appropriately. This article identifies three distinct classifications of patients with diabetes approaching the ends of their lives due to advanced illnesses. The authors propose a specific framework to guide management in patients with diabetes and advanced disease who are relatively stable, experiencing impending death or organ failure, or actively dying. The authors provide comprehensive information on commonly used diabetic medications, with necessary considerations and dose adjustments for these populations. The goal of the approach is to address individual patient needs, provide guidance for patients and caregivers, and ultimately maximize outcomes for patients with diabetes in the palliative care setting.

Entities:  

Mesh:

Year:  2010        PMID: 21194302     DOI: 10.1089/jpm.2010.0191

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  5 in total

1.  Hypoglycemia in Hospice Patients With Type 2 Diabetes in a National Sample of Nursing Homes.

Authors:  Laura A Petrillo; Siqi Gan; Bocheng Jing; Sean Lang-Brown; W John Boscardin; Sei J Lee
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

2.  13. Older Adults: Standards of Medical Care in Diabetes-2022.

Authors:  Boris Draznin; Vanita R Aroda; George Bakris; Gretchen Benson; Florence M Brown; RaShaye Freeman; Jennifer Green; Elbert Huang; Diana Isaacs; Scott Kahan; Jose Leon; Sarah K Lyons; Anne L Peters; Priya Prahalad; Jane E B Reusch; Deborah Young-Hyman
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 19.112

Review 3.  Decision making about change of medication for comorbid disease at the end of life: an integrative review.

Authors:  Ronald T C M van Nordennen; Jan C M Lavrijsen; Kris C P Vissers; Raymond T C M Koopmans
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

Review 4.  Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life.

Authors:  Denise Soltow Hershey
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Oct-Dec

Review 5.  Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association.

Authors:  Medha N Munshi; Hermes Florez; Elbert S Huang; Rita R Kalyani; Maria Mupanomunda; Naushira Pandya; Carrie S Swift; Tracey H Taveira; Linda B Haas
Journal:  Diabetes Care       Date:  2016-02       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.